Azitra (NYSEAMERICAN:AZTR) Trading Down 2.6% – Here’s What Happened

Azitra, Inc. (NYSEAMERICAN:AZTR) traded down 2.6% on Wednesday . The company traded as low as $0.77 and last traded at $0.78. 115,559 shares were traded during trading, a decline of 99% from the average session volume of 7,980,780 shares. The stock had previously closed at $0.80.

Azitra Trading Down 2.6%

The firm has a 50-day moving average of $1.13 and a two-hundred day moving average of $1.69.

Hedge Funds Weigh In On Azitra

A hedge fund recently raised its stake in Azitra stock. National Bank of Canada FI grew its position in shares of Azitra, Inc. (NYSEAMERICAN:AZTR) by 175.0% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 110,000 shares of the company’s stock after purchasing an additional 70,000 shares during the quarter. National Bank of Canada FI owned approximately 0.88% of Azitra worth $34,000 as of its most recent SEC filing. Institutional investors and hedge funds own 11.16% of the company’s stock.

About Azitra

Azitra, Inc, an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease.